PPIs, H2RAs reduce GI bleeding in critically ill patients
10 Feb 2020
bởiStephen Padilla
Use of proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) significantly reduces gastrointestinal (GI) bleeding in critically ill patients, reveals a systematic review and meta-analysis. However, reduction in bleeding is unimportant in low-risk patients.
PPIs, H2RAs reduce GI bleeding in critically ill patients
10 Feb 2020